| Identification | Back Directory | [Name]
tert-Butyl N-(4-hydroxy-1-methylcyclohexyl)carbamate | [CAS]
792913-83-8 | [Synonyms]
tert-Butyl (4-hydroxy-1-Methylcyclohexyl)carbaMate
tert-butyl N-(4-hydroxy-1-methylcyclohexyl)carbamate
2-Methyl-2-propanyl(4-hydroxy-1-Methylcyclohexyl)carbaMate
(4-Hydroxy-1-methyl-cyclohexyl)-carbamic acid tert-butyl ester
(4-hydroxy-1-methylcyclohexyl)Carbamic acid 1,1-dimethylethyl ester
CarbaMic acid, (4-hydroxy-1-Methylcyclohexyl)-, 1,1-diMethylethyl ester
Carbamic acid, N-(4-hydroxy-1-methylcyclohexyl)-, 1,1-dimethylethyl ester
Carbamic acid, (4-hydroxy-1-methylcyclohexyl)-, 1,1-dimethylethyl ester (9CI) | [Molecular Formula]
C12H23NO3 | [MDL Number]
MFCD20040473 | [MOL File]
792913-83-8.mol | [Molecular Weight]
229.32 |
| Chemical Properties | Back Directory | [Boiling point ]
339.9±31.0 °C(Predicted) | [density ]
1.05±0.1 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [pka]
12.77±0.40(Predicted) |
| Hazard Information | Back Directory | [Uses]
tert-Butyl N-(4-hydroxy-1-methylcyclohexyl)carbamate is a pharmaceutical intermediate used in the preparation of RAF kinase inhibitors. |
|
| Company Name: |
BePharm Ltd
|
| Tel: |
400-685-9117 |
| Website: |
www.bepharm.com |
|